Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism
William L. Holland(Southwestern Medical Center), Scott A. Summers(University of Utah)
Cited by 575
Related Papers
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in mice
|Journal of Clinical Investigation|2011|680
Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease
|Journal of Clinical Investigation|2019|243
Metabolic dysfunction and obesity‐related cancer: Beyond obesity and metabolic syndrome
|Obesity|2022|159
Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation
|Biochemical Journal|2001|63